Ultrasmall superparamagnetic iron oxide particles (AMI 227) as a blood pool contrast agent for MR angiography: Experimental study in rabbits

The purpose of this study was to evaluate the contribution of an ultrasmall superparamagnetic iron oxide particles (USPIOs) based contrast agent (AMI 227), in a transverse three‐dimensional time‐of‐flight TONE MR angiography sequence of abdominal aorta in rabbits. The main goal was to assess improvement in the visualization of small arteries such as renal arteries, when using such a sequence. Imaging experiments were performed on a 1.5 T magnet, using a transverse 3D time‐of‐flight (TOF) tilted optimized nonsaturating excitation (TONE) sequence with magnetization transfer suppression. The contrast media used were composed of a USPIO core surrounded by a dextransurfactant (AMI 227). Different concentrations of AMI 227 were evaluated in 12 rabbits. Concentrations varied within the range 8.5–34 μmol Fe/kg‐bw: 8.5 μmol Fe/kg (three rabbits); 17 μmol Fe/kg (three rabbits); 25.5 μmol Fe/kg (three rabbits); 34 μmol Fe/kg (three rabbits). A visual analysis based on the improvement of visualization of small arteries (renal arteries) on MIP images and a quantitative analysis based on the percentage of contrast enhancement of the aorta plotted against distance in the slab from the top edge of the acquisition volume were obtained. A signal‐to‐noise ratio enhancement of the distal part of the aorta and only improvement in the delineation of the renal arteries were noted when using low concentrations of the contrast media. A loss of signal‐to‐noise ratio of the aorta and a decrease in arterial visualization were respectively noted with higher concentration of contrast media. In this experimental study, using a transverse three‐dimensional TOF TONE MR angiography sequence of renal arteries, in which sequence the saturation effect is minimized, the use of AMI 227 allows only improvement in the delineation.

[1]  S. Saini,et al.  MR contrast material for vascular enhancement: value of superparamagnetic iron oxide. , 1996, AJR. American journal of roentgenology.

[2]  H. Bosmans,et al.  Time-of-flight MR angiography of the brain: comparison of acquisition techniques in healthy volunteers. , 1995, AJR. American journal of roentgenology.

[3]  M. Schaefer,et al.  Paramagnetic dextrans as magnetic resonance blood pool tracers. , 1994, Investigative radiology.

[4]  S Berr,et al.  Three‐dimensional time‐of‐flight MR angiography using selective inversion recovery RAGE with fat saturation and ECG‐triggering: Application to renal arteries , 1994, Magnetic resonance in medicine.

[5]  D Atkinson,et al.  Improved MR angiography: magnetization transfer suppression with variable flip angle excitation and increased resolution. , 1994, Radiology.

[6]  M. Prince.  Gadolinium-enhanced MR aortography. , 1990, Radiology.

[7]  R. Weissleder,et al.  Enhancement of MR angiography with iron oxide: preliminary studies in whole-blood phantom and in animals. , 1994, AJR. American journal of roentgenology.

[8]  D. Parker,et al.  Contrast-to-Noise-Ratio Measurements in Three-Dimensional Magnetic Resonance Angiography , 1993, Investigative radiology.

[9]  J A Frank,et al.  Frequency dependence of MR relaxation times II. Iron oxides , 1993, Journal of magnetic resonance imaging : JMRI.

[10]  R Weissleder,et al.  A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies. , 1993, Radiology.

[11]  Hendrick Re,et al.  Basic physics of MR contrast agents and maximization of image contrast , 1993, Journal of magnetic resonance imaging : JMRI.

[12]  D Revel,et al.  Superparamagnetic iron oxide particles and positive enhancement for myocardial perfusion studies assessed by subsecond T1-weighted MRI. , 1993, Magnetic resonance imaging.

[13]  G. Frija,et al.  Superparamagnetic iron oxides as positive MR contrast agents: in vitro and in vivo evidence. , 1993, Magnetic resonance imaging.

[14]  Magnetic Resonance Angiography Techniques , 1992, Investigative radiology.

[15]  D Chien,et al.  Improved time-of-flight MR angiography of the brain with magnetization transfer contrast. , 1992, Radiology.

[16]  R. Brasch.  New directions in the development of MR imaging contrast media. , 1992, Radiology.

[17]  A. Roch,et al.  Transverse relaxivity of particulate MRI contrast media: From theories to experiments , 1991, Magnetic resonance in medicine.

[18]  H Bosmans,et al.  Experimental Gd-DTPA polylysine enhanced MR angiography: sequence optimization. , 1991, Journal of computer assisted tomography.

[19]  S. Ogawa,et al.  Magnetic resonance imaging of blood vessels at high fields: In vivo and in vitro measurements and image simulation , 1990, Magnetic resonance in medicine.

[20]  H. Bosmans,et al.  MR angiography with gadopentetate dimeglumine-polylysine: evaluation in rabbits. , 1990, AJR. American journal of roentgenology.

[21]  A L Baert,et al.  Intracranial vascular lesions: optimization and clinical evaluation of three-dimensional time-of-flight MR angiography. , 1990, Radiology.

[22]  M. Moseley,et al.  Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues. , 1990, Radiology.

[23]  R. Weissleder,et al.  Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. , 1990, Radiology.

[24]  H. Kantor,et al.  Signal loss induced by superparamagnetic iron oxide particle in NMR spin‐echo images: The role of diffusion , 1990, Magnetic resonance in medicine.

[25]  M E Moseley,et al.  Vascular Mapping using Albumin‐(Gd‐DTPA), an Intravascular MR Contrast Agent, and Projection MR Imaging , 1989, Journal of computer assisted tomography.

[26]  L. Josephson,et al.  The effects of iron oxides on proton relaxivity. , 1988, Magnetic resonance imaging.

[27]  R. Henkelman.  Measurement of signal intensities in the presence of noise in MR images. , 1985, Medical physics.